JAKs report 8% growth in sales during H1 FY26
The Jan Aushadhi Kendras (JAKs) under the flagship scheme of Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) run by the Department of Pharmaceuticals (DoP), has reported a growth of 8% in sales during the
Read the full report on Pharma Biz
Story file
- Section
- Health
- Topics
- Government schemes
- First reported by
- Pharma Biz
- Published
- Monday, 26 October 2026, 8:00 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Pharma Biz with a short summary and a link to the original. The original reporting belongs to the publisher. Spotted an error in our summary? Tell our corrections desk.



